We support our sponsors with cutting-edge processes including protocol design, site training, and real-time data quality analysis. Our focus is on creating efficient, effective, and patient-centric trial designs that address the specific challenges of CNS studies.
Our proprietary technology enables real-time monitoring and analysis of data, ensuring high-quality and reliable outcomes. This continuous oversight allows us to quickly identify and address any issues, maintaining the integrity of the clinical trial.
The incomplete understanding of neurobiology contributes to CNS clinical development programs having some of the highest failure rates across all therapeutic areas. Clinicalae is dedicated to overcoming these challenges through advanced research and innovative methodologies.
CNS trials often face significant challenges in managing placebo response. We employ sophisticated strategies to mitigate these effects, ensuring more accurate and reliable results.
Incorporating soft endpoints and focusing on patient-centric designs help in reducing patient burden, making it easier for participants to adhere to study protocols and improving the overall quality of data collected.